Company / Depreciation & Amortization
Anixa Biosciences Inc Depreciation & Amortization History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$38.3K
FY2022
5-year range
$18.4K / $47.6K
FY2018-FY2022
Trend
-19.5%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has fluctuated over the past 6 years, ranging from $12,515 in FY2016 to $47,558 in FY2020.
Based on SEC 10-K filings.
$38,276 in FY2022 with a 5-year CAGR of +2.8%.
Increased from $18,435 to $38,276 over the past 3 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +27.6%
- 5-Year CAGR
- +2.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +2.8%, indicating consistent growth.
- In FY2022, depreciation & amortization decreased 19.5% year-over-year.
- Peak depreciation & amortization was recorded in FY2020.
- Lowest depreciation & amortization in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.53 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $38.3K | -19.5% |
| FY2020 | $47.6K | +158.0% |
| FY2019 | $18.4K | -57.3% |
| FY2018 | $43.2K | +29.6% |
| FY2017 | $33.3K | +166.3% |
| FY2016 | $12.5K | - |
| FY2015 | - | - |
| FY2014 | - | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026